United States · FDA National Drug Code directory
Ribavirin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-290_229cfa05-05e1-493e-87ba-0511fed12e66
- Product NDC
- 65862-290
- Form
- CAPSULE
- Composition / generic term
- Ribavirin
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090917
- Source listing expiry
- 20261231
Source-listed ingredients
- RIBAVIRIN — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (65862-290-05) · 65862-290-05
- 180 CAPSULE in 1 BOTTLE (65862-290-18) · 65862-290-18
- 42 CAPSULE in 1 BOTTLE (65862-290-42) · 65862-290-42
- 56 CAPSULE in 1 BOTTLE (65862-290-56) · 65862-290-56
- 70 CAPSULE in 1 BOTTLE (65862-290-70) · 65862-290-70
- 84 CAPSULE in 1 BOTTLE (65862-290-84) · 65862-290-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →